Prognostic factors add criteria to treat Waldenstrom's macroglobulinemia.

被引：0
|
作者：
Morel, P
Duhamel, A
Dimopoulos, M
San Miguel, J
Barlogie, B
Kyle, R
Leblond, V
Dhodapkar, M
Mc Coy, J
Treon, S
Gobbi, PG
Merlini, G
机构：
[1] Hop Schaffner, Lens, France
[2] Univ Hosp, Ctr Etud & Rech Informat Med, Lille, France
[3] Univ Athens, Athens, Greece
[4] Hosp Univ, Salamanca, Spain
[5] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[6] Mayo Clin, Rochester, MN USA
[7] Hop La Pitie Salpetriere, Paris, France
[8] SW Oncol Grp, Seattle, WA USA
[9] Dana Farber Canc Inst, Boston, MA 02115 USA
[10] IRCCS Policlin San Matteo, Biotechnol Res Labs, Pavia, Italy
[11] Univ Pavia, I-27100 Pavia, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：261 / 262
页数：2
相关论文
共 50 条
  • [1] Waldenstrom's macroglobulinemia.
    Wulf, G
    Pool, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11): : 816 - 816
  • [2] Waldenstrom's macroglobulinemia.
    Ilinca-Pruzan, C
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 : 47 - 47
  • [3] Waldenstrom's macroglobulinemia.
    Finkel, HE
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10): : 784 - 784
  • [4] Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia.
    Dimopolous, MA
    Hamilos, G
    Symeonidis, A
    Kouvatseas, G
    Zervas, K
    Panayiotidis, P
    Gika, D
    Karmiris, T
    Bouradas, K
    Grigoraki, V
    Zomas, A
    Anagnostopoulos, N
    Economopoulos, T
    BLOOD, 2002, 100 (11) : 604A - 604A
  • [5] Molecular cytogenetics in Waldenstrom's Macroglobulinemia.
    Ocio, EM
    González, B
    Castellanos, M
    Gutiérrez, NC
    Moro, MJ
    Aguilera, C
    Frade, JG
    Rivas, JMH
    San Miguel, JF
    BLOOD, 2003, 102 (11) : 684A - 684A
  • [6] Clinical responses to sildenafil in Waldenstrom's macroglobulinemia.
    Treon, SR
    Tournilhac, O
    Branagan, A
    Hunter, Z
    Xu, LA
    Hatjiharissi, E
    Santos, DD
    BLOOD, 2004, 104 (11) : 313B - 313B
  • [7] The International Prognostic Index (IPI) for multiple myeloma is applicable in Waldenstrom's macroglobulinemia.
    Dimopoulos, MA
    Zervas, K
    Kyrtsonis, MC
    Symeonidis, A
    Anagnostopoulos, A
    Gika, D
    Bourantas, K
    Zomas, A
    Anagnostopoulos, N
    Pangalis, G
    BLOOD, 2003, 102 (11) : 362B - 362B
  • [8] Prognostic factors in symptomatic Waldenstrom's macroglobulinemia
    Merlini, G
    Baldini, L
    Broglia, C
    Comelli, M
    Goldaniga, M
    Palladini, G
    Deliliers, GL
    Gobbi, PG
    SEMINARS IN ONCOLOGY, 2003, 30 (02) : 211 - 215
  • [9] Waldenstrom macroglobulinemia - Development of diagnostic criteria and identification of prognostic factors
    Owen, RG
    Barrans, SL
    Richards, SJ
    O'Connor, SJM
    Child, JA
    Parapia, LA
    Morgan, GJ
    Jack, AS
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (03) : 420 - 428
  • [10] Clarithromycin, thalidomide and dexamethasone for the treatment of Waldenstrom's macroglobulinemia.
    Dimopoulos, MA
    Tsatalas, C
    Zomas, A
    Hamilos, G
    Panayiotidis, P
    Anagnostopoulos, N
    Gika, D
    Margaritis, D
    Economopoulos, T
    BLOOD, 2002, 100 (11) : 384B - 384B
12345